ARCHIVES

Texas Oncology Designated Aranesp As Preferred Treatment

This article is from The Cancer Letter archive.

Vol. 28 No. 46 | December 13, 2002

Download PDF Visit The Full Archive

Related Articles

M.D. Anderson signs collaboration agreement with Institut Gustave Roussy.

February 13, 2004

Young Investigators Hold Their Own

September 28, 1979

NSABP Breast Cancer Prevention Trial Reports Final Results On Tamoxifen

November 25, 2005

In Brief: Eppley Is The “New” Center Getting an NCI Core; USC Appoints Jones Basic Science Chief

May 4, 1984

Bush Limits Drug Company Efforts To Block Generics

October 25, 2002

Pittsburgh Cancer Institute Gets NCI Core Grants

June 24, 1988